Health Care Policy
-
Sickle Cell Disease Still Tends to Be Overlooked
Gary Freed Quoted in the New York Times
Sickle cell disease affects about 100,000 Americans, most of them African-Americans. There are few treatments for it, and experts say not enough is being done to prevent complications. Read more
-
Study Suggests Medicare Program Aimed at Lowering Costs, Improving Care May Not Working as Well as Thought
New Research from Andrew Ryan and Adam Markovitz
Accountable care organizations’ achievements in "bending the cost curve" may reflect the departure of high-cost physicians, according to new research lead by researchers at the University of Michigan School of Public Health and Michigan Medicine. Read more
-
Edward Norton Recognized for Excellence in Research
Edward C. Norton
Looking closely at how we use quality metrics to determine compensation, Edward Norton’s research has shifted our study of long-term care management from institutional providers to informal family care for the elderly. Read more
-
IN THE NEWS: Don't Just Blame Drug Companies for the Opioid Crisis...
New Contribution from Rebecca Haffajee
The causes driving the opioid crisis are more complex than just the actions of pharmaceutical companies. A fragmented health care system, ineffective policies, and current federal and state laws are all contributing to the level of difficulty when it comes to combating overdoses and addiction within the United States. Read more
-
IN THE NEWS: Opinion: Lower Out-Of-Pocket Drug Costs for Needy
New Op/Ed from A. Mark Fendrick
Making medications more affordable would improve the health of the most vulnerable among us. In some circumstances, it could even reduce total health care spending by averting preventable hospitalizations and emergency room visits. Read more
-
No-Deal Brexit Will Have Serious Negative Health Effects
New Research from Holly Jarman
A no-deal Brexit would make it harder for the United Kingdom to recruit health workers into their system, will jeopardize continuing care for British citizens with pre-existing conditions living outside the U.K., and could even lead to an increase in cardiovascular disease-related deaths, say researchers. Read more
